1 completed, 1 recruiting. 2 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Completed 1, Recruiting 1 |
| Phase 3 | 1 | Recruiting 1 |
Follow Cardiovascular: new trials by email Literature Review of Cardiovascular trials Research Report on Cardiovascular
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Focusing on the Menopausal Transition to Improve Mid-Life Women's Health Metformin, semaglutide, Anti-hypertensives - Menopause, Menopause Hot Flashes | Phase 2 / Phase 3 | Recruiting | University of Colorado, Denver | 200 | 2026-03-01 | 2026-11-04 |
| Fortifying Healthy Behaviors, Optimizing Medical Therapies and Enhancing Cognitive Function in Older Adults-pilot Study Risk managment, Dasatinib, Quercetin (dietary supplement) - Aging, Cognitive Decline | Phase 2 | Completed | Washington University School of Medicine | 23 | 2025-07-28 | 2026-08-19 |
Cognitive Dysfunction (1) · Sedentary Behavior (1)
Behavior (1) · Cognition Disorders (1) · Mental Disorders (1) · Neurocognitive Disorders (1)
Angiotensin Receptor Antagonists (1) · Antihypertensive Agents (1) · Dasatinib (1) · Dietary Supplements (1) · Metformin (1) · Quercetin (1) · Vortioxetine (1) · fezolinetant (1) · semaglutide (1)
University of Colorado, Denver (1) · Washington University School of Medicine (1)
United States (2)
Eric Lenze, MD (1) · Nanette Santoro, MD (1)